Sandy Omrod has 16 years experience in the pharmaceutical industry holding positions in Production and Quality Assurance with emphasis in sterile and solid oral dosage forms. Sandy joined AstraZeneca in 2000 as a Production Supervisor for sterile products and then later a Principle Compliance Specialist for solid oral dosages. Prior to joining AstraZeneca, Sandy was employed at Wyeth with responsibility for validation and manufacturing activities for Parenterals. In 2010, Sandy joined Global Quality Operations at AstraZeneca as a Global Quality Manager. She provides technical consultation to worldwide sites relating to AstraZeneca’s Quality and Compliance standards, external GMP requirements and Quality Systems expectations to ensure they are understood, interpreted and applied consistently. Sandy is primarily focused on monitoring and interpreting signals to identify trends and potential risk areas through global process ownership of deviations, regulatory inspection observations, and Quality Key Performance Indicators (KPI). She has developed and implemented many standardized global processes. She was instrumental in developing and implementing a standardized global process for production sites to report Quality Key Performance Indicators ensuring that potential quality and compliance risks are identified proactively, escalated, and mitigated.